Immune Response to Cancer Therapy

Mounting an Effective Antitumor Response and Mechanisms of Resistance

Terry R. Medler, Tiziana Cotechini, Lisa Coussens

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Chemotherapy and radiotherapy have been extensively used to eradicate cancer based on their direct cytocidal effects on rapidly proliferating tumor cells. Accumulating evidence indicates that these therapies also dramatically affect resident and recruited immune cells that actively support tumor growth. We now appreciate that mobilization of effector CD8+ T cells enhances the efficacy of chemotherapy and radiotherapy; remarkable clinical advances have been achieved by blocking regulatory programs limiting cytotoxic CD8+ T cell activity. This review discusses immune-mediated mechanisms underlying the efficacy of chemotherapy and radiotherapy, and provides a perspective on how understanding tissue-based immune mechanisms can be used to guide therapeutic approaches combining immune and cytotoxic therapies to improve outcomes for a larger subset of patients than is currently achievable.

Original languageEnglish (US)
Pages (from-to)66-75
Number of pages10
JournalTrends in Cancer
Volume1
Issue number1
DOIs
StatePublished - Sep 1 2015

Fingerprint

Radiotherapy
Drug Therapy
T-Lymphocytes
Neoplasms
Therapeutics
Growth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Immune Response to Cancer Therapy : Mounting an Effective Antitumor Response and Mechanisms of Resistance. / Medler, Terry R.; Cotechini, Tiziana; Coussens, Lisa.

In: Trends in Cancer, Vol. 1, No. 1, 01.09.2015, p. 66-75.

Research output: Contribution to journalArticle

@article{ce8ba0c561e64de69f9093eede413f6f,
title = "Immune Response to Cancer Therapy: Mounting an Effective Antitumor Response and Mechanisms of Resistance",
abstract = "Chemotherapy and radiotherapy have been extensively used to eradicate cancer based on their direct cytocidal effects on rapidly proliferating tumor cells. Accumulating evidence indicates that these therapies also dramatically affect resident and recruited immune cells that actively support tumor growth. We now appreciate that mobilization of effector CD8+ T cells enhances the efficacy of chemotherapy and radiotherapy; remarkable clinical advances have been achieved by blocking regulatory programs limiting cytotoxic CD8+ T cell activity. This review discusses immune-mediated mechanisms underlying the efficacy of chemotherapy and radiotherapy, and provides a perspective on how understanding tissue-based immune mechanisms can be used to guide therapeutic approaches combining immune and cytotoxic therapies to improve outcomes for a larger subset of patients than is currently achievable.",
author = "Medler, {Terry R.} and Tiziana Cotechini and Lisa Coussens",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.trecan.2015.07.008",
language = "English (US)",
volume = "1",
pages = "66--75",
journal = "Trends in Cancer",
issn = "2405-8033",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Immune Response to Cancer Therapy

T2 - Mounting an Effective Antitumor Response and Mechanisms of Resistance

AU - Medler, Terry R.

AU - Cotechini, Tiziana

AU - Coussens, Lisa

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Chemotherapy and radiotherapy have been extensively used to eradicate cancer based on their direct cytocidal effects on rapidly proliferating tumor cells. Accumulating evidence indicates that these therapies also dramatically affect resident and recruited immune cells that actively support tumor growth. We now appreciate that mobilization of effector CD8+ T cells enhances the efficacy of chemotherapy and radiotherapy; remarkable clinical advances have been achieved by blocking regulatory programs limiting cytotoxic CD8+ T cell activity. This review discusses immune-mediated mechanisms underlying the efficacy of chemotherapy and radiotherapy, and provides a perspective on how understanding tissue-based immune mechanisms can be used to guide therapeutic approaches combining immune and cytotoxic therapies to improve outcomes for a larger subset of patients than is currently achievable.

AB - Chemotherapy and radiotherapy have been extensively used to eradicate cancer based on their direct cytocidal effects on rapidly proliferating tumor cells. Accumulating evidence indicates that these therapies also dramatically affect resident and recruited immune cells that actively support tumor growth. We now appreciate that mobilization of effector CD8+ T cells enhances the efficacy of chemotherapy and radiotherapy; remarkable clinical advances have been achieved by blocking regulatory programs limiting cytotoxic CD8+ T cell activity. This review discusses immune-mediated mechanisms underlying the efficacy of chemotherapy and radiotherapy, and provides a perspective on how understanding tissue-based immune mechanisms can be used to guide therapeutic approaches combining immune and cytotoxic therapies to improve outcomes for a larger subset of patients than is currently achievable.

UR - http://www.scopus.com/inward/record.url?scp=84957836940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957836940&partnerID=8YFLogxK

U2 - 10.1016/j.trecan.2015.07.008

DO - 10.1016/j.trecan.2015.07.008

M3 - Article

VL - 1

SP - 66

EP - 75

JO - Trends in Cancer

JF - Trends in Cancer

SN - 2405-8033

IS - 1

ER -